Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT00858377
Title A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications
Therapies
Age Groups: adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Research Site Tucson Arizona 85724 United States Details
Research Site Los Angeles California 90095 United States Details
Research Site Baltimore Maryland 21231 United States Details
Research Site Las Vegas Nevada 89148 United States Details
Research Site Albuquerque New Mexico 87131 United States Details
Research Site Kurralta Park South Australia 5037 Australia Details
Research Site Bentleigh East Victoria 3165 Australia Details
Research Site Parkville Victoria 3050 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field